Suppr超能文献

阐明了穿心莲内酯混悬液的粒径效应对其口服吸收的 IVIVC 性能的影响。

Elucidating the particle size effect of andrographolide suspensions on their IVIVC performance in oral absorption.

机构信息

Department of Pharmaceutics, School of Pharmacy, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.

Department of Sanitary Chemistry, School of Public Health, Shenyang Medical College, No. 146 Yellow River North Street, Shenyang 110034, China.

出版信息

Eur J Pharm Biopharm. 2022 Oct;179:65-73. doi: 10.1016/j.ejpb.2022.08.012. Epub 2022 Sep 2.

Abstract

The study aimed to explore the size effect on the in vitro-in vivo correlation (IVIVC) in the oral absorption of andrographolide nanosuspensions (Ag-NS). Ag-NS with controllable particle sizes were prepared by ultrasonic dispersion method, and the formulation and process parameters were optimized through single factor experiments using mean particle size, polydispersity index, and stability as evaluation indicators. The morphology of Ag-NS was observed by scanning electron microscopy (SEM), and the crystalline state of the nanosuspensions was characterized by X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC). The dissolution tests were carried out with the paddle method in two different mediums simulating the pH conditions in intestinal fluid (pH 6.8) and gastric fluid (pH 1.2), respectively. The pharmacokinetic behaviors were investigated in rats after oral administration, and a deconvolution approach was introduced to determine the correlation between in vitro dissolution and in vivo absorption (IVIVC). The formulation with the use of lecithin and PEG-800 as stabilizers showed its potential in the size-controllable preparation of Ag-NS. Via altering the ultrasonication amplitude and time, three Ag-NS suspensions with three particle sizes, i.e., Ag-NS 250 (249.8 ± 1.3 nm), Ag-NS 450 (485.2 ± 3.7 nm), Ag-NS 1000 (1015 ± 36.1 nm) were prepared. Their morphological and crystal characteristics were not changed during the size reduction process, but both of their in vitro dissolution and in vivo absorption were improved. Relatively better IVIVC performance was observed with the in vitro dissolution data at pH 6.8 (r > 0.9). With the reduction of particle size, the in vivo absorption fraction was more closed to the level of the in vitro dissolution. In conclusion, the decrease in particle size would improve the dissolution and absorption of Ag-NS, and also affect their IVIVC performance. The study would facilitate the design and quality control of Ag-NS in terms of particle size and dissolution specifications.

摘要

本研究旨在探讨在口服吸收过程中,大小效应对穿心莲内酯纳米混悬剂(Ag-NS)的体外-体内相关性(IVIVC)的影响。采用超声分散法制备可控粒径的 Ag-NS,通过单因素实验,以平均粒径、多分散指数和稳定性为评价指标,对制剂处方和工艺参数进行优化。采用扫描电子显微镜(SEM)观察 Ag-NS 的形态,采用 X 射线粉末衍射(XRPD)和差示扫描量热法(DSC)对纳米混悬剂的晶型进行表征。采用桨法在两种不同介质中进行溶出试验,分别模拟肠液(pH 6.8)和胃液(pH 1.2)的 pH 值条件。通过大鼠口服给药研究其药代动力学行为,并采用解卷积法确定体外溶出度与体内吸收的相关性(IVIVC)。采用卵磷脂和 PEG-800 作为稳定剂的配方在 Ag-NS 的可控粒径制备中表现出潜力。通过改变超声幅度和时间,制备了三种粒径的 Ag-NS 混悬液,即 Ag-NS 250(249.8±1.3nm)、Ag-NS 450(485.2±3.7nm)和 Ag-NS 1000(1015±36.1nm)。在粒径减小过程中,它们的形态和晶体特性没有发生变化,但体外溶出度和体内吸收都得到了提高。在 pH 6.8 时,体外溶出度数据观察到相对较好的 IVIVC 性能(r>0.9)。随着粒径的减小,体内吸收分数更接近体外溶出度的水平。总之,粒径的减小会提高 Ag-NS 的溶出度和吸收度,也会影响它们的 IVIVC 性能。该研究将有助于根据粒径和溶出度规格设计和控制 Ag-NS 的质量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验